Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 8/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 2/20 | 0.39 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.39 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.37 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3266560 | 0.76 | GRM2 (0.42) | KCNA3GRM2GSK3BSMYD3 | |
| SCHEMBL13925852 | 0.75 | GRM2 (0.48) | KCNA3GRM2SMYD3 | |
| SCHEMBL24253400 | 0.74 | KCNA3 (0.41) | KCNA3GRM2GSK3BSMYD3 | |
| SCHEMBL27284572 | 0.73 | KCNA3 (0.46) | KCNA3GRM2 | |
| SCHEMBL24501920 | 0.73 | QPCT (0.45) | QPCTALPLPLAAGSK3BALPG | |
| SCHEMBL10924270 | 0.73 | SMN1; SMN2 (0.58) | — | |
| SCHEMBL14416042 | 0.73 | KDM4E (0.57) | QPCT | |
| SCHEMBL1178203 | 0.72 | ALDH1A1 (0.64) | — | |
| SCHEMBL12911102 | 0.72 | P2RX7 (0.42) | KCNA3GRM2GSK3BSMYD3 | |
| SCHEMBL22231667 | 0.72 | KCNA3 (0.39) | KCNA3GRM2GSK3BSMYD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG-A ST CO., LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086709-A1 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | GALE, UGDH, PGLS | QPCT 998/4885KCNA3 2909/4885GRM2 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.